Status:
UNKNOWN
Molecular Diagnosis of Allergic Contact Dermatitis (SMECA).
Lead Sponsor:
Ramsay Générale de Santé
Collaborating Sponsors:
Institut National de la Santé Et de la Recherche Médicale, France
Conditions:
Eczema
Allergic Contact Eczema Nos
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Allergic contact dermatitis (ACD) is a common inflammatory skin disease, which represents a major public health issue in industrialized countries. ACD is induced by repeated contact of individuals wit...
Eligibility Criteria
Inclusion
- Patient, male or female, over 18 years of age.
- Patient with at least one positive/doubtful patch test reaction for nickel, limonene hydroperoxide and/or linalool hydroperoxide
- Patient agreeing to undergo skin biopsies and blood sampling
- Patient agreeing to non-identifying pictures being taken of lesions
- Patient available to carry out skin tests and their interpretation
- Patient affiliated to or benefiting from a social security regime
- Patient having been informed and having signed a written, free and informed consent.
Exclusion
- Patient with active dermatitis lesions on the forearm
- Patient with a history of allergic reaction to a local anesthetic product
- Patient with wound healing disorders (hypertrophic or keloids scars)
- Patient with hematological disorders
- Patient having topical treatments with corticosteroids or immunomodulators on the forearms during the 21 days prior to the start of the study
- Patient having had excessive exposure to ultraviolet during the 21 days prior to the start of the study.
- Patient on systemic corticosteroid therapy, immunosuppressants or biological therapy.
- Patient whose follow-up is impossible for reasons psychological or geographical.
- Patient taking part in another clinical study
- Protected patient: adult under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision
- Pregnant, breast-feeding or parturient woman
Key Trial Info
Start Date :
June 20 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 20 2024
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06124781
Start Date
June 20 2023
End Date
December 20 2024
Last Update
November 9 2023
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinique universitaire Saint Luc
Brussels, Belgium
2
CHU de Grenoble
La Tronche, France, 38700
3
CHU Lyon Sud
Pierre-Bénite, France, 69495
4
Hopital Privé de la Loire
Saint-Etienne, France, 42100